Measles, Mumps, And Rubella (mmr) Vaccine - Public Health

Relevant Publications

The impact of temperature, humidity and closing school on the mumps epidemic: a case study in the mainland of China.

Issue Release: 2024

Shedding of measles vaccine RNA in children after receiving measles, mumps and rubella vaccination.

Issue Release: 2024

Questionable Immunity to Mumps among Healthcare Workers in Italy-A Cross-Sectional Serological Study.

Issue Release: 2024

Information and vaccine hesitancy: The role of broadband Internet.

Issue Release: 2024

Serological responses to immunization during nephrosis in infants with congenital nephrotic syndrome of the Finnish type.

Issue Release: 2024

Vaccine Coverage at 36 Months and 7 Years by Parental Birth Country, Washington State.

Issue Release: 2024

Mumps in Poland in 2021.

Issue Release: 2024

Measles, mumps, rubella, and varicella antibodies among international and domestic university students.

Issue Release: 2024

Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study.

Issue Release: 2024

Live-attenuated vaccination for measles, mumps, and rubella in pediatric liver transplantation.

Issue Release: 2024

Measles-specific antibodies loss after a single dose of MMR vaccine in children with oligo-articular JIA on methotrexate treatment: a single-center case-controlled study.

Issue Release: 2024

Acute Pancreatitis Induced by COVID-19 Vaccine: A Systematic Review.

Issue Release: 2024

Systematic Review of Intralesional Therapies for Cutaneous Warts.

Issue Release: 2024

A Review of the Resurgence of Measles, a Vaccine-Preventable Disease, as Current Concerns Contrast with Past Hopes for Measles Elimination.

Issue Release: 2024

Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels - United States, May 2022-April 2023.

Issue Release: 2024

Increasing measles, mumps, and rubella (MMR) vaccine uptake in primary care.

Issue Release: 2024

Adverse events following Measles-Mumps-Rubella and varicella immunization: A safety profile analysis and comparison of different vaccination schedules based on the Italian Pharmacovigilance Network in the Veneto Region.

Issue Release: 2024

Long-term persistence of seroprotection against measles following measles-mumps-rubella vaccination administered before and after pediatric liver transplantation.

Issue Release: 2024

Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study.

Issue Release: 2024

Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database.

Issue Release: 2024

What are Coronaviruses?

What is Data Privacy in Public Health?

Why Should I Get Vaccinated?

What Are Aflatoxins?

What is Chronic Care Management?

How Do Healthcare Technologies Address Health Inequities?

What are some key emerging technologies in Public Health?

What Are the Public Health Interventions for Aflatoxin Exposure?

Why is Food Safety Important in Public Health?

How Can Public Health Initiatives Improve Food Safety?

Partnered Content Networks

Relevant Topics